HCW Biologics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HCW Biologics Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was -$63.50K.
- HCW Biologics Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was -$70.09K.
- HCW Biologics Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was -$22.30K.
- HCW Biologics Inc. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $49.24M.
- HCW Biologics Inc. stock issued during period, value, new issues for fiscal 2025 was -$269.68K.
- HCW Biologics Inc. stock issued during period, value, new issues for fiscal 2024 was -$226.20K.
- HCW Biologics Inc. stock issued during period, value, new issues for fiscal 2021 was $49.24M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | -$269.68K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$63.50K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$70.09K 10-Q · filed 2025-11-14 | |
| 2025-03-31 | -$22.30K 10-Q/A · filed 2026-08-14 | |
| 2024-12-31 | -$226.20K 10-K · filed 2026-03-31 | |
| 2021-12-31 | $49.24M 10-K · filed 2022-03-29 | |
| 2021-09-30 | $49.24M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |